new and special drug
-

Adempas (Riociguat) – CTEPH/PAH | HongKong DengYue Medicine
-

Ariane (Rezvilutamide) – mHSPC | HongKong DengYue Medicine
-

Baiyueda (Sonrotoclax) – CLL/SLL/MCL | HongKong DengYue Medicine
-

Inlyta (Axitinib) – RCC | HongKong DengYue Medicine
-

VUMON (Teniposide) – Antineoplastic Agent | HongKong DengYue Medicine
-

ILUMETRI (Tildrakizumab) – Tlaque Psoriasis | HongKong DengYue Medicine
-

KESIMPTA (Ofatumumab) – Multiple Sclerosis | HongKong DengYue Medicine
-

Aimovig (Erenumab Injection) – Migraine | HongKong DengYue Medicine
-

Takhzyro lanadelumab-flyo injection – Hereditary Angioedema | HongKong DengYue Medicine
-

Cuprior (Trientrine Tetrahydrochloride) – Wilson’s Disease | HongKong DengYue Medicine
-

Entinostat Tablets – HDAC | HongKong DengYue Medicine
-

SOTYKTU (Deucravacitinib Tablets) – Psoriasis | HongKong DengYue Medicine
-

Fampyra Comprimidos (Fampridine) – Multiple Sclerosis | HongKong DengYue Medicine
-

RAVICTI (Glycerol Phenylbutyrate) – Reduce Blood Ammonia Levels | DengYue
-

RYBELSUS (Semaglutide) – T2DM | HongKong DengYue Medicine
-

Vascepa® (Icosapent Ethyl) – Hypertriglyceridaemia | HongKong DengYue Medicine
















